explore -WSS

explore

author：hotspot 2025-10-01 00:14:29 - browse：3264

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： How Vertex's cystic fibrosis drug is changing patients' lives

WSS

Experts study whether long Covid risk adds up with each reinfection

Emergency workers more likely to restrain Black patients: study

Senate HELP committee spars over health care workforce policies

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

A biotech analyst on neuroscience, placebo effect, not over

focus

explore

hotspot

In age of alternative facts, a scholarly course on calling out crap

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Affirmative action in medical school literally saved lives

Experts study whether long Covid risk adds up with each reinfection

In age of alternative facts, a scholarly course on calling out crap

Senators: Long

BioMarin wins approval for gene therapy to treat hemophilia A

Emergent cuts jobs, executive role in business shake

State Dept. review finds Biden bears some blame for Afghanistan failures

The best solution to the drug shortages problem

hotspot

Maui's cultural, historic landmarks damaged in the devastating wildfires

It's been 20 years since Dolly the sheep. Where's my clone?

Emergency workers more likely to restrain Black patients: study

What Congress can do to address the rural doctor shortage

Drug for rare kidney disease narrowly misses mark in clinical trial

Biotech stock slump in 2023: awaiting the turnaround

Wikipedia

explore

entertainment

knowledge